News

Sobi and Biogen Idec flesh out details of hemophilia programs

06-02-2012

Stockholm-based Swedish Orphan Biovitrum (STO: SOBI) and US biotech company Biogen Idec (Nasdaq: BIIB)…

Biogen IdecBiotechnologyCardio-vascularLicensingPharmaceuticalSwedish Orphan Biovitrum

Sobi buys rights to novel neonatology treatment

16-01-2012

Stockholm-based Swedish Orphan Biovitrum (STO: SOBI) has signed a global licensing agreement with the…

BumetanideCardio-vascularLicensingNeurologicalOnly for Children PharmaceuticalsPharmaceuticalSwedish Orphan Biovitrum

Pharming plans to file Rhucin BLA with US FDA by end 2010

31-08-2010

Netherlands-based biotechnology company Pharming Group NV (NYSE Euronext: PHARM) says that it intends…

BiotechnologyCardio-vascularFinancialLicensingPharmaceuticalPharmingRegulationRhucinSwedish Orphan Biovitrum

COMPANY SPOTLIGHT

Menarini

Back to top